Browsing by Author "Lunetta, Christian (7801365932)"
Now showing 1 - 6 of 6
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Clinical trials in pediatric ALS: a TRICALS feasibility study(2022) ;Kliest, Tessa (57218861339) ;Van Eijk, Ruben P.A. (56124096700) ;Al-Chalabi, Ammar (7003751621) ;Albanese, Alberto (7101798303) ;Andersen, Peter M. (55762260653) ;Amador, Maria Del Mar (56779749800) ;BrÅthen, Geir (55761743400) ;Brunaud-Danel, Veronique (8401178200) ;Brylev, Lev (23110301900) ;Camu, William (7003581532) ;De Carvalho, Mamede (7101893769) ;Cereda, Cristina (23495596100) ;Cetin, Hakan (18533793500) ;Chaverri, Delia (56737507900) ;Chiò, Adriano (7006225787) ;Corcia, Philippe (7003468084) ;Couratier, Philippe (7004512376) ;De Marchi, Fabiola (56385357700) ;Desnuelle, Claude (36879066900) ;Van Es, Michael A. (21740232100) ;Esteban, JesÚs (56421529400) ;Filosto, Massimiliano (57209161436) ;GarcÍa Redondo, Alberto (57191529460) ;Grosskreutz, Julian (55880962700) ;Hanemann, Clemens O. (7003471503) ;HolmØy, Trygve (12762206100) ;HØyer, Helle (35976246500) ;Ingre, Caroline (37088702900) ;Koritnik, Blaz (23482155600) ;Kuzma-Kozakiewicz, Magdalena (23025276100) ;Lambert, Thomas (57468047700) ;Leigh, Peter N. (57220539946) ;Lunetta, Christian (7801365932) ;Mandrioli, Jessica (6507337687) ;Mcdermott, Christopher J. (57210226457) ;Meyer, Thomas (57206879525) ;Mora, Jesus S. (57208572268) ;Petri, Susanne (56740505800) ;Povedano, MÓnica (15754423400) ;Reviers, Evy (57217991411) ;Riva, Nilo (18234080500) ;Roes, Kit C.B. (6602457345) ;Rubio, Miguel Á. (37762043600) ;Salachas, FranÇois (8595576400) ;Sarafov, Stayko (6507897016) ;SorarÙ, Gianni (57222417541) ;Stevic, Zorica (57204495472) ;Svenstrup, Kirsten (6505759760) ;MØller, Anette Torvin (13608428400) ;Turner, Martin R. (57210974952) ;Van Damme, Philip (7101714325) ;Van Leeuwen, Lucie A.G. (56506920400) ;Varona, Luis (7005698381) ;VÁzquez Costa, Juan F. (54785443500) ;Weber, Markus (55737067000) ;Hardiman, Orla (57201275401)Van Den Berg, Leonard H. (56843401500)Background: Pediatric investigation plans (PIPs) describe how adult drugs can be studied in children. In 2015, PIPs for Amyotrophic Lateral Sclerosis (ALS) became mandatory for European marketing-authorization of adult treatments, unless a waiver is granted by the European Medicines Agency (EMA). Objective: To assess the feasibility of clinical studies on the effect of therapy in children (<18 years) with ALS in Europe. Methods: The EMA database was searched for submitted PIPs in ALS. A questionnaire was sent to 58 European ALS centers to collect the prevalence of pediatric ALS during the past ten years, the recruitment potential for future pediatric trials, and opinions of ALS experts concerning a waiver for ALS. Results: Four PIPs were identified; two were waived and two are planned for the future. In total, 49 (84.5%) centers responded to the questionnaire. The diagnosis of 44,858 patients with ALS was reported by 46 sites; 39 of the patients had an onset < 18 years (prevalence of 0.008 cases per 100,000 or 0.087% of all diagnosed patients). The estimated recruitment potential (47 sites) was 26 pediatric patients within five years. A majority of ALS experts (75.5%) recommend a waiver should apply for ALS due to the low prevalence of pediatric ALS. Conclusions: ALS with an onset before 18 years is extremely rare and may be a distinct entity from adult ALS. Conducting studies on the effect of disease-modifying therapy in pediatric ALS may involve lengthy recruitment periods, high costs, ethical/legal implications, challenges in trial design and limited information. © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. - Some of the metrics are blocked by yourconsent settings
Publication Clinical trials in pediatric ALS: a TRICALS feasibility study(2022) ;Kliest, Tessa (57218861339) ;Van Eijk, Ruben P.A. (56124096700) ;Al-Chalabi, Ammar (7003751621) ;Albanese, Alberto (7101798303) ;Andersen, Peter M. (55762260653) ;Amador, Maria Del Mar (56779749800) ;BrÅthen, Geir (55761743400) ;Brunaud-Danel, Veronique (8401178200) ;Brylev, Lev (23110301900) ;Camu, William (7003581532) ;De Carvalho, Mamede (7101893769) ;Cereda, Cristina (23495596100) ;Cetin, Hakan (18533793500) ;Chaverri, Delia (56737507900) ;Chiò, Adriano (7006225787) ;Corcia, Philippe (7003468084) ;Couratier, Philippe (7004512376) ;De Marchi, Fabiola (56385357700) ;Desnuelle, Claude (36879066900) ;Van Es, Michael A. (21740232100) ;Esteban, JesÚs (56421529400) ;Filosto, Massimiliano (57209161436) ;GarcÍa Redondo, Alberto (57191529460) ;Grosskreutz, Julian (55880962700) ;Hanemann, Clemens O. (7003471503) ;HolmØy, Trygve (12762206100) ;HØyer, Helle (35976246500) ;Ingre, Caroline (37088702900) ;Koritnik, Blaz (23482155600) ;Kuzma-Kozakiewicz, Magdalena (23025276100) ;Lambert, Thomas (57468047700) ;Leigh, Peter N. (57220539946) ;Lunetta, Christian (7801365932) ;Mandrioli, Jessica (6507337687) ;Mcdermott, Christopher J. (57210226457) ;Meyer, Thomas (57206879525) ;Mora, Jesus S. (57208572268) ;Petri, Susanne (56740505800) ;Povedano, MÓnica (15754423400) ;Reviers, Evy (57217991411) ;Riva, Nilo (18234080500) ;Roes, Kit C.B. (6602457345) ;Rubio, Miguel Á. (37762043600) ;Salachas, FranÇois (8595576400) ;Sarafov, Stayko (6507897016) ;SorarÙ, Gianni (57222417541) ;Stevic, Zorica (57204495472) ;Svenstrup, Kirsten (6505759760) ;MØller, Anette Torvin (13608428400) ;Turner, Martin R. (57210974952) ;Van Damme, Philip (7101714325) ;Van Leeuwen, Lucie A.G. (56506920400) ;Varona, Luis (7005698381) ;VÁzquez Costa, Juan F. (54785443500) ;Weber, Markus (55737067000) ;Hardiman, Orla (57201275401)Van Den Berg, Leonard H. (56843401500)Background: Pediatric investigation plans (PIPs) describe how adult drugs can be studied in children. In 2015, PIPs for Amyotrophic Lateral Sclerosis (ALS) became mandatory for European marketing-authorization of adult treatments, unless a waiver is granted by the European Medicines Agency (EMA). Objective: To assess the feasibility of clinical studies on the effect of therapy in children (<18 years) with ALS in Europe. Methods: The EMA database was searched for submitted PIPs in ALS. A questionnaire was sent to 58 European ALS centers to collect the prevalence of pediatric ALS during the past ten years, the recruitment potential for future pediatric trials, and opinions of ALS experts concerning a waiver for ALS. Results: Four PIPs were identified; two were waived and two are planned for the future. In total, 49 (84.5%) centers responded to the questionnaire. The diagnosis of 44,858 patients with ALS was reported by 46 sites; 39 of the patients had an onset < 18 years (prevalence of 0.008 cases per 100,000 or 0.087% of all diagnosed patients). The estimated recruitment potential (47 sites) was 26 pediatric patients within five years. A majority of ALS experts (75.5%) recommend a waiver should apply for ALS due to the low prevalence of pediatric ALS. Conclusions: ALS with an onset before 18 years is extremely rare and may be a distinct entity from adult ALS. Conducting studies on the effect of disease-modifying therapy in pediatric ALS may involve lengthy recruitment periods, high costs, ethical/legal implications, challenges in trial design and limited information. © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. - Some of the metrics are blocked by yourconsent settings
Publication Physical activity and amyotrophic lateral sclerosis: A European population-based case-control study(2014) ;Pupillo, Elisabetta (26424797500) ;Messina, Paolo (53663869800) ;Giussani, Giorgia (57200843076) ;Logroscino, Giancarlo (7004888005) ;Zoccolella, Stefano (6508069845) ;Chiò, Adriano (7006225787) ;Calvo, Andrea (57208095998) ;Corbo, Massimo (7006723926) ;Lunetta, Christian (7801365932) ;Marin, Benoit (8436867400) ;Mitchell, Douglas (15062951900) ;Hardiman, Orla (57201275401) ;Rooney, James (57202998117) ;Stevic, Zorica (57204495472) ;di Poggio, Monica Bandettini (24280491300) ;Filosto, Massimiliano (57209161436) ;Cotelli, Maria Sofia (58754789900) ;Perini, Michele (57200423475) ;Riva, Nilo (18234080500) ;Tremolizzo, Lucio (57200719476) ;Vitelli, Eugenio (58306414700) ;Damiani, Danira (57215382236) ;Beghi, Ettore (7004809655) ;Al-Chalabi, Ammar (7003751621) ;Ludolph, Albert (26643359400) ;Preux, Pierre-Marie (57200708442) ;Swingler, Robert (7003557258) ;van den Berg, Leonard (56843401500) ;Addison, Robert (57200295505) ;Alvisi, Elena (57192308502) ;Astegiano, Giovanni (57211481303) ;Bonito, Virgilio (6603242582) ;Bottacchi, Edo (7003377832) ;Buzzi, Paolo (6507291118) ;Canosa, Antonio (15838973400) ;Capozzo, Rosa (36467923800) ;Caponnetto, Claudia (6603631671) ;Cavallo, Roberto (24544725800) ;Ceroni, Mauro (56608910700) ;Chiveri, Luca (6603424799) ;Corti, Stefania (7003759380) ;Couratier, Philippe (7004512376) ;Delodovici, Luisa (55530388600) ;Durelli, Luca (7006960663) ;Ferrarese, Carlo (7005869087) ;Ferrero, Bruno (35837724200) ;Fetoni, Vincenza (6602504435) ;Gallo, Sara (57213624498) ;Geda, Claudio (6507878516) ;Ghiglione, Paolo (7801588388) ;Gionco, Maurizio (6508011341) ;Guaita, Maria Cristina (55747126000) ;Joyce, Gardham (57200300712) ;Launaro, Nicola (57189688844) ;Lynch, Catherine (22956155900) ;Lorusso, Lorenzo (6701393076) ;Maestri, Eleonora (57199664681) ;Magliola, Umberto (12785460200) ;Marchet, Alberto (59050686200) ;Mauro, Alessandro (7004566307) ;Mazzini, Letizia (7003390256) ;Micheli, Anna (7005491423) ;Milicev, Milena (55243221400) ;Millul, Andrea (6508044955) ;Montesano, Mariagrazia (55848982600) ;Padovani, Alessandro (55996824100) ;Palazzini, Elena (7006541142) ;Palermo, Mario (59569918000) ;Papurello, Diego (56256991500) ;Pastore, Ilaria (6507088342) ;Penza, Maria Teresa (7003747865) ;Perrone, Patrizia (7003801822) ;Pisano, Fabrizio (57525070900) ;Prelle, Alessandro (7003497579) ;Preux, Pierre-Marie (7005931092) ;Ranieri, Michela (26535071800) ;Regio, Valentina (56423776600) ;Rigamonti, Andrea (57218434000) ;Sasanelli, Francesco (6603339103) ;Secchi, Patrizia (7003583424) ;Smith, Jennifer (58598223500) ;Tavernelli, Fiorella (54882263200) ;Vergnano, Franco (57138282800) ;Villani, Angelo (57211481279) ;Arbore, Giuseppe (57200300560) ;Case, Nadia (57200291369) ;Del Sordo, Novella (57200298787) ;Di Landro, Alfredo (57200295808) ;Leali, Nicoletta (56919685000) ;Masini, Lino (57200292291) ;Matuonto, Vincenzo (57200298863) ;Monticelli, Maria Luisa (56585697500) ;Montini, Adriana (57200297335) ;Palumbo, Marco (57200288141) ;Parati, Angelo (57200298781) ;Pellegrino, Sergio (57210688521) ;Sessa, Aurelio (7006450747) ;Severgnini, Enrico (57200288158)Vertué, Gianluigi (56919602100)Objective To assess whether physical activity is a risk factor for amyotrophic lateral sclerosis (ALS). Methods From February 2008 to April 2012, 652 patients with ALS from European population-based registries (France, Ireland, Italy, United Kingdom, Serbia) and 1,166 population controls (matched for age, sex, and residency) were assessed. Upon direct interview, data were collected on occupation and history of sport and leisure activities, physical activity, and accidental injuries. Physical exercise was defined as having spent time doing activities that caused an individual to breath hard at least once per month and was coded as none, job-related, and/or sport-related. Sport-related and work-related physical exercise were quantified using metabolic equivalents (METs). Risks were calculated using conditional logistic regression models (adjusting for age, country, trauma, and job-related physical activity) and expressed as odds ratios (ORs) and adjusted ORs (Adj ORs) with 95% confidence intervals (CIs). Results Overall physical activity was associated with reduced odds of having ALS (Adj OR = 0.65, 95% CI = 0.48-0.89) as were work-related physical activity (Adj OR = 0.56, 95% CI = 0.36-0.87) and organized sports (Adj OR = 0.49, 95% CI = 0.32-0.75). An inverse correlation was observed between ALS, the duration of physical activity (p = 0.0041), and the cumulative MET scores, which became significant for the highest exposure (Adj OR = 0.34, 95% CI = 0.21-0.54). An inverse correlation between ALS and sport was found in women but not in men, and in subjects with repeated traumatic events. Interpretation Physical activity is not a risk factor for ALS and may eventually be protective against the disease. © 2014 American Neurological Association. - Some of the metrics are blocked by yourconsent settings
Publication Physical activity and amyotrophic lateral sclerosis: A European population-based case-control study(2014) ;Pupillo, Elisabetta (26424797500) ;Messina, Paolo (53663869800) ;Giussani, Giorgia (57200843076) ;Logroscino, Giancarlo (7004888005) ;Zoccolella, Stefano (6508069845) ;Chiò, Adriano (7006225787) ;Calvo, Andrea (57208095998) ;Corbo, Massimo (7006723926) ;Lunetta, Christian (7801365932) ;Marin, Benoit (8436867400) ;Mitchell, Douglas (15062951900) ;Hardiman, Orla (57201275401) ;Rooney, James (57202998117) ;Stevic, Zorica (57204495472) ;di Poggio, Monica Bandettini (24280491300) ;Filosto, Massimiliano (57209161436) ;Cotelli, Maria Sofia (58754789900) ;Perini, Michele (57200423475) ;Riva, Nilo (18234080500) ;Tremolizzo, Lucio (57200719476) ;Vitelli, Eugenio (58306414700) ;Damiani, Danira (57215382236) ;Beghi, Ettore (7004809655) ;Al-Chalabi, Ammar (7003751621) ;Ludolph, Albert (26643359400) ;Preux, Pierre-Marie (57200708442) ;Swingler, Robert (7003557258) ;van den Berg, Leonard (56843401500) ;Addison, Robert (57200295505) ;Alvisi, Elena (57192308502) ;Astegiano, Giovanni (57211481303) ;Bonito, Virgilio (6603242582) ;Bottacchi, Edo (7003377832) ;Buzzi, Paolo (6507291118) ;Canosa, Antonio (15838973400) ;Capozzo, Rosa (36467923800) ;Caponnetto, Claudia (6603631671) ;Cavallo, Roberto (24544725800) ;Ceroni, Mauro (56608910700) ;Chiveri, Luca (6603424799) ;Corti, Stefania (7003759380) ;Couratier, Philippe (7004512376) ;Delodovici, Luisa (55530388600) ;Durelli, Luca (7006960663) ;Ferrarese, Carlo (7005869087) ;Ferrero, Bruno (35837724200) ;Fetoni, Vincenza (6602504435) ;Gallo, Sara (57213624498) ;Geda, Claudio (6507878516) ;Ghiglione, Paolo (7801588388) ;Gionco, Maurizio (6508011341) ;Guaita, Maria Cristina (55747126000) ;Joyce, Gardham (57200300712) ;Launaro, Nicola (57189688844) ;Lynch, Catherine (22956155900) ;Lorusso, Lorenzo (6701393076) ;Maestri, Eleonora (57199664681) ;Magliola, Umberto (12785460200) ;Marchet, Alberto (59050686200) ;Mauro, Alessandro (7004566307) ;Mazzini, Letizia (7003390256) ;Micheli, Anna (7005491423) ;Milicev, Milena (55243221400) ;Millul, Andrea (6508044955) ;Montesano, Mariagrazia (55848982600) ;Padovani, Alessandro (55996824100) ;Palazzini, Elena (7006541142) ;Palermo, Mario (59569918000) ;Papurello, Diego (56256991500) ;Pastore, Ilaria (6507088342) ;Penza, Maria Teresa (7003747865) ;Perrone, Patrizia (7003801822) ;Pisano, Fabrizio (57525070900) ;Prelle, Alessandro (7003497579) ;Preux, Pierre-Marie (7005931092) ;Ranieri, Michela (26535071800) ;Regio, Valentina (56423776600) ;Rigamonti, Andrea (57218434000) ;Sasanelli, Francesco (6603339103) ;Secchi, Patrizia (7003583424) ;Smith, Jennifer (58598223500) ;Tavernelli, Fiorella (54882263200) ;Vergnano, Franco (57138282800) ;Villani, Angelo (57211481279) ;Arbore, Giuseppe (57200300560) ;Case, Nadia (57200291369) ;Del Sordo, Novella (57200298787) ;Di Landro, Alfredo (57200295808) ;Leali, Nicoletta (56919685000) ;Masini, Lino (57200292291) ;Matuonto, Vincenzo (57200298863) ;Monticelli, Maria Luisa (56585697500) ;Montini, Adriana (57200297335) ;Palumbo, Marco (57200288141) ;Parati, Angelo (57200298781) ;Pellegrino, Sergio (57210688521) ;Sessa, Aurelio (7006450747) ;Severgnini, Enrico (57200288158)Vertué, Gianluigi (56919602100)Objective To assess whether physical activity is a risk factor for amyotrophic lateral sclerosis (ALS). Methods From February 2008 to April 2012, 652 patients with ALS from European population-based registries (France, Ireland, Italy, United Kingdom, Serbia) and 1,166 population controls (matched for age, sex, and residency) were assessed. Upon direct interview, data were collected on occupation and history of sport and leisure activities, physical activity, and accidental injuries. Physical exercise was defined as having spent time doing activities that caused an individual to breath hard at least once per month and was coded as none, job-related, and/or sport-related. Sport-related and work-related physical exercise were quantified using metabolic equivalents (METs). Risks were calculated using conditional logistic regression models (adjusting for age, country, trauma, and job-related physical activity) and expressed as odds ratios (ORs) and adjusted ORs (Adj ORs) with 95% confidence intervals (CIs). Results Overall physical activity was associated with reduced odds of having ALS (Adj OR = 0.65, 95% CI = 0.48-0.89) as were work-related physical activity (Adj OR = 0.56, 95% CI = 0.36-0.87) and organized sports (Adj OR = 0.49, 95% CI = 0.32-0.75). An inverse correlation was observed between ALS, the duration of physical activity (p = 0.0041), and the cumulative MET scores, which became significant for the highest exposure (Adj OR = 0.34, 95% CI = 0.21-0.54). An inverse correlation between ALS and sport was found in women but not in men, and in subjects with repeated traumatic events. Interpretation Physical activity is not a risk factor for ALS and may eventually be protective against the disease. © 2014 American Neurological Association. - Some of the metrics are blocked by yourconsent settings
Publication Trauma and amyotrophic lateral sclerosis: a european population-based case-control study from the EURALS consortium(2018) ;Pupillo, Elisabetta (26424797500) ;Poloni, Marco (7004956993) ;Bianchi, Elisa (56622371300) ;Giussani, Giorgia (57200843076) ;Logroscino, Giancarlo (7004888005) ;Zoccolella, Stefano (6508069845) ;Chiò, Adriano (7006225787) ;Calvo, Andrea (57208095998) ;Corbo, Massimo (7006723926) ;Lunetta, Christian (7801365932) ;Marin, Benoit (8436867400) ;Mitchell, Douglas (15062951900) ;Hardiman, Orla (57201275401) ;Rooney, James (57202998117) ;Stevic, Zorica (57204495472) ;Bandettini di Poggio, Monica (24280491300) ;Filosto, Massimiliano (57209161436) ;Cotelli, Maria Sofia (59292762800) ;Perini, Michele (57200423475) ;Riva, Nilo (18234080500) ;Tremolizzo, Lucio (57200719476) ;Vitelli, Eugenio (6603266669) ;Damiani, Danira (57215382236)Beghi, Ettore (7004809655)Objectives: To assess the association between amyotrophic lateral sclerosis (ALS) and previous traumatic events, age of trauma, and site of injury. Methods: A population-based case-control study was performed in five European countries (Italy, Ireland, France, United Kingdom, Serbia). Newly diagnosed ALS patients and matched controls were interviewed to collect relevant demographic factors and exposures. Key clinical features at diagnosis were collected in ALS patients. Trauma was any accidental event causing an injury. Injuries were dated and classified according to cause, severity, type, site, and complications. All exposures were censored five years before symptoms onset. Risks were computed as odds ratios (OR) with 95% confidence intervals (CI) using univariate and multivariate conditional logistic regression models. Results: Five hundred and seventy-five ALS patients and 1150 controls were interviewed. Disabling traumatic events predominated in the cases (OR 1.54 (95% CI 1.24–1.92)) and maintained significance after adjustment, with a significant gradient. A history of 2 + head injuries was associated with an almost three-fold increased risk of ALS. The risk was almost two-fold when trauma occurred at age 35–54 years. Site of injury was uneventful. Conclusions: Traumatic events leading to functional disability or confined to the head are risk factors for ALS. Traumatic events experienced at age 35–54 years carry the highest risk. © 2017 World Federation of Neurology on behalf of the Research Group on Motor Neuron Diseases. - Some of the metrics are blocked by yourconsent settings
Publication Trauma and amyotrophic lateral sclerosis: a european population-based case-control study from the EURALS consortium(2018) ;Pupillo, Elisabetta (26424797500) ;Poloni, Marco (7004956993) ;Bianchi, Elisa (56622371300) ;Giussani, Giorgia (57200843076) ;Logroscino, Giancarlo (7004888005) ;Zoccolella, Stefano (6508069845) ;Chiò, Adriano (7006225787) ;Calvo, Andrea (57208095998) ;Corbo, Massimo (7006723926) ;Lunetta, Christian (7801365932) ;Marin, Benoit (8436867400) ;Mitchell, Douglas (15062951900) ;Hardiman, Orla (57201275401) ;Rooney, James (57202998117) ;Stevic, Zorica (57204495472) ;Bandettini di Poggio, Monica (24280491300) ;Filosto, Massimiliano (57209161436) ;Cotelli, Maria Sofia (59292762800) ;Perini, Michele (57200423475) ;Riva, Nilo (18234080500) ;Tremolizzo, Lucio (57200719476) ;Vitelli, Eugenio (6603266669) ;Damiani, Danira (57215382236)Beghi, Ettore (7004809655)Objectives: To assess the association between amyotrophic lateral sclerosis (ALS) and previous traumatic events, age of trauma, and site of injury. Methods: A population-based case-control study was performed in five European countries (Italy, Ireland, France, United Kingdom, Serbia). Newly diagnosed ALS patients and matched controls were interviewed to collect relevant demographic factors and exposures. Key clinical features at diagnosis were collected in ALS patients. Trauma was any accidental event causing an injury. Injuries were dated and classified according to cause, severity, type, site, and complications. All exposures were censored five years before symptoms onset. Risks were computed as odds ratios (OR) with 95% confidence intervals (CI) using univariate and multivariate conditional logistic regression models. Results: Five hundred and seventy-five ALS patients and 1150 controls were interviewed. Disabling traumatic events predominated in the cases (OR 1.54 (95% CI 1.24–1.92)) and maintained significance after adjustment, with a significant gradient. A history of 2 + head injuries was associated with an almost three-fold increased risk of ALS. The risk was almost two-fold when trauma occurred at age 35–54 years. Site of injury was uneventful. Conclusions: Traumatic events leading to functional disability or confined to the head are risk factors for ALS. Traumatic events experienced at age 35–54 years carry the highest risk. © 2017 World Federation of Neurology on behalf of the Research Group on Motor Neuron Diseases.
